The pharma giant reported strong financial results in Q4FY24, supported by robust performance in the US and domestic markets. The revenue growth was majorly led by the US market in…
The post StoxBox: Views on Sun Pharma Industries Ltd. Q4 FY24 Result first appeared on Business News Week.